Insider Transactions Reported by 22 Insiders of NRX Pharmaceuticals, Inc.

Symbol
NRXP, NRXPW on Nasdaq
Location
Wilmington, DE

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

NRX Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
B Group, Inc. 10%+ Owner $8,820,000 18 Aug 2025
Daniel C. Javitt 10%+ Owner $3,082,170 29 Nov 2022
Jonathan C. Javitt Chairman and Chief Scientist, Director, 10%+ Owner $1,774,696 09 Apr 2025
BRAC Lending Group LLC 10%+ Owner $188,880 24 May 2021
Big Rock Partners Sponsor, LLC 10%+ Owner $166,129 24 May 2021
William Fricker CFO & Treasurer $39,680 24 May 2021
Aaron Gorovitz Director $33,590 30 Aug 2023
Daniel Troy Director $26,872 24 May 2021
Seth van Voorhees Chief Financial Officer $20,062 16 Dec 2022
Stephen H. Willard CHIEF EXECUTIVE OFFICER, Director $15,995 16 Dec 2022
Alessandra Daigneault General Counsel & Secretary $15,891 19 Aug 2021
Michael S. Abrams Chief Financial Officer $10,000 07 Feb 2025
Herbert Raymond McMaster Director $9,126 26 Aug 2021
Sharon A. Glied Director 21 Oct 2022
Robert Besthof Interim CEO 08 Mar 2022
Patrick John Flynn Director 09 Apr 2025
Richard Clavano Narido Interim CFO 13 Sep 2023
Ira S. Strassberg Chief Financial Officer 15 Mar 2022
Chaim Hurvitz Director 09 Apr 2025
Janet Rehnquist Director 28 Dec 2023
Dennis McBride Director 09 Apr 2025
Joseph M. Casper Chief Operating Officer 27 Jan 2026

Recent Insider Transactions by Companies or Individuals for NRX Pharmaceuticals, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Joseph M. Casper NRXP Stock Option (right to buy) Award 100,000 100,000 27 Jan 2026 Direct
Jonathan C. Javitt NRXP Stock Option (right to buy) Award 125,000 125,000 09 Apr 2025 Direct
Dennis McBride NRXP Stock Option (right to buy) Award 25,000 25,000 09 Apr 2025 Direct
Chaim Hurvitz NRXP Stock Option (right to buy) Award 25,000 25,000 09 Apr 2025 Direct
Patrick John Flynn NRXP Stock Option (right to buy) Award 50,000 50,000 09 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.